Zuzanna Fimińska
Zuzanna Fimińska
Latest posts from :
Pharma's poor image is making it difficult to readily enter into fruitful...
Customized treatments are the final step in putting patients at the center of...
Web-based portals, social media, and connected devices offer an opportunity to...
As budgets shrink, crowdfunding offers an opportunity to derisk investment.
Problems begin when transparency and communication fail says EFPIA's Andie...
How can pharma use observational data to support discovery, research &...
We look at an adherence toolbox, which allows patients and HCPs to achieve...
Could trials be at risk of being invalidated by rebellion from patients?
Alzheimer’s disease is a ticking time bomb for public health around the...
With a staggering cost of drug development estimated at US$2.6 billion and a...